Compare GPMT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | RCEL |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | 226 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.9M | 132.0M |
| IPO Year | N/A | N/A |
| Metric | GPMT | RCEL |
|---|---|---|
| Price | $1.76 | $5.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $3.00 | ★ $7.17 |
| AVG Volume (30 Days) | ★ 234.4K | 231.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.36% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $543.95 | $21.69 |
| Revenue Next Year | $33.91 | $49.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $3.22 |
| 52 Week High | $3.12 | $10.28 |
| Indicator | GPMT | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 64.31 |
| Support Level | $1.64 | $4.92 |
| Resistance Level | $2.71 | $5.88 |
| Average True Range (ATR) | 0.10 | 0.40 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 16.91 | 62.92 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.